Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1.38 Million |
|---|---|
| Enterprise Value | $261.06 Million |
| Earnings per Share | $0 |
| Beta | 0.51 |
| Outstanding Shares | 3,444,470,933 |
| P/E Ratio | -14.94 |
|---|---|
| PEG | -0.3 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -711.11 |
| Enterprise Value to Net Income | -647 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -2.19 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is dedicated to the development and commercialization of its specialized protein-based therapies. Its primary focus is on addressing severe infectious illnesses. The com...